Cumberland Pharmaceuticals Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Cumberland Pharmaceuticals.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Pharmaceuticals winstgroei | 23.7% |
Inkomstengroei | n/a |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | None |
Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Recent updates
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Nov 04Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Mar 07Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Prospects Need A Boost To Lift Shares
Jan 09Why Investors Shouldn't Be Surprised By Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Low P/S
Oct 02Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Aug 10Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Have A Healthy Balance Sheet?
Mar 18Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Nov 02Calculating The Fair Value Of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)
Jul 20Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Apr 15Checking In On Cumberland Pharmaceuticals
Jan 04Health Check: How Prudently Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Use Debt?
Nov 09We Think Some Shareholders May Hesitate To Increase Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) CEO Compensation
Apr 21Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Debt In A Risky Way?
Feb 13One Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Analyst Just Cut Their EPS Forecasts
Nov 19Cumberland Pharmaceuticals Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 11In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Cumberland Pharmaceuticals onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
6/30/2024 | 38 | -10 | -1 | -1 | N/A |
3/31/2024 | 39 | -8 | 5 | 5 | N/A |
12/31/2023 | 40 | -6 | 6 | 6 | N/A |
9/30/2023 | 39 | -2 | 7 | 9 | N/A |
6/30/2023 | 41 | -2 | 8 | 10 | N/A |
3/31/2023 | 40 | -4 | 5 | 7 | N/A |
12/31/2022 | 42 | -6 | 6 | 8 | N/A |
9/30/2022 | 41 | -7 | 6 | 7 | N/A |
6/30/2022 | 38 | -9 | 4 | 4 | N/A |
3/31/2022 | 37 | -7 | 4 | 4 | N/A |
12/31/2021 | 36 | -6 | 6 | 6 | N/A |
9/30/2021 | 38 | -3 | 5 | 5 | N/A |
6/30/2021 | 39 | -3 | 5 | 6 | N/A |
3/31/2021 | 40 | -5 | 5 | 6 | N/A |
12/31/2020 | 37 | -7 | 3 | 5 | N/A |
9/30/2020 | 36 | -8 | 3 | 5 | N/A |
6/30/2020 | 34 | -10 | 4 | 5 | N/A |
3/31/2020 | 34 | -10 | 3 | 4 | N/A |
12/31/2019 | 34 | -9 | 2 | 3 | N/A |
9/30/2019 | 39 | -8 | 3 | 6 | N/A |
6/30/2019 | 40 | -6 | 0 | 4 | N/A |
3/31/2019 | 41 | -6 | -2 | 2 | N/A |
12/31/2018 | 29 | -11 | -1 | 3 | N/A |
9/30/2018 | 39 | -6 | -3 | -1 | N/A |
6/30/2018 | 42 | -5 | 0 | 2 | N/A |
3/31/2018 | 40 | -9 | N/A | -2 | N/A |
12/31/2017 | 41 | -8 | N/A | -1 | N/A |
9/30/2017 | 39 | -8 | N/A | 1 | N/A |
6/30/2017 | 36 | -7 | N/A | 0 | N/A |
3/31/2017 | 35 | -2 | N/A | 1 | N/A |
12/31/2016 | 33 | -1 | N/A | 1 | N/A |
9/30/2016 | 32 | 0 | N/A | 1 | N/A |
6/30/2016 | 31 | 0 | N/A | 1 | N/A |
3/31/2016 | 33 | 0 | N/A | 4 | N/A |
12/31/2015 | 34 | 1 | N/A | 6 | N/A |
9/30/2015 | 35 | 1 | N/A | 7 | N/A |
6/30/2015 | 37 | 2 | N/A | 9 | N/A |
3/31/2015 | 37 | 2 | N/A | 8 | N/A |
12/31/2014 | 37 | 2 | N/A | 7 | N/A |
9/30/2014 | 36 | 0 | N/A | 4 | N/A |
6/30/2014 | 33 | -1 | N/A | 1 | N/A |
3/31/2014 | 30 | -3 | N/A | 0 | N/A |
12/31/2013 | 32 | -2 | N/A | 1 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if CPIX's forecast earnings growth is above the savings rate (2.5%).
Winst versus markt: Insufficient data to determine if CPIX's earnings are forecast to grow faster than the US market
Hoge groeiwinsten: Insufficient data to determine if CPIX's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if CPIX's revenue is forecast to grow faster than the US market.
Hoge groei-inkomsten: Insufficient data to determine if CPIX's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if CPIX's Return on Equity is forecast to be high in 3 years time